
Calpime 1 Injection
Marketer
H & I Critical Care
Salt Composition
Cefepime (1000mg)
Overview Calpime 1 Injection
Bactrum IV is a potent antibacterial agent effective against a wide range of bacteria. Indicated for serious bacterial infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream, it acts by bacterial eradication. Importantly, it's ineffective against viral infections. Bactrum IV is frequently administered to hospitalized patients in critical condition. Intravenous delivery, either by infusion or direct injection, is strictly under medical or nursing supervision. Dosage is individualized based on infection type, location, and severity. Treatment duration must be completed as prescribed, even with rapid symptom improvement; premature cessation risks relapse or exacerbation. Adverse effects, such as skin rash, pruritus, nausea, emesis, cephalalgia, pyrexia, diarrhea, or localized injection site inflammation, may occur; these are typically transient and resolve with continued therapy. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any pre-existing renal or hepatic dysfunction, or antibiotic allergies. Regular blood tests to assess kidney function may be recommended during therapy. Generally, Bactrum IV is considered safe for pregnant and lactating individuals under medical guidance.
Primary Ingredients of Calpime 1 Injection
No information provided. A rephrased version cannot be created.
Uses of Calpime 1 Injection
Managing life-threatening bacterial illnesses
Major Benefits of Calpime 1 Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Calpime 1 Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Calpime 1 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Calpime 1 Injection works:
Calpime 1 Injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby hindering the bacteria's ability to survive.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Calpime 1 Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Administering Calpime 1 Injection during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Calpime 1 Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to the infant. However, extended Calpime 1 Injection use should be avoided due to potential side effects like diarrhea and skin rashes.
DrivingCONSULT YOUR DOCTOR
The effect of Calpime 1 Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Calpime 1 Injection with care. The prescribed dosage of Calpime 1 Injection might require modification. Seek medical advice from your physician.
LiverSAFE IF PRESCRIBED
The use of Calpime 1 Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is advised.
What if you forget to take Calpime 1 Injection :
Omit a Calpime 1 Injection dose? Seek medical advice.
Facts to Know About Calpime 1 Injection
| Label | Value |
|---|---|
| Chemical Type | Cephalosporins (third and fourth generation) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Fourth-Generation Cephalosporins |
